SU‐E‐T‐693: Surface Dose Reduction from Bone Interface in Superficial X‐Ray Radiation Therapy: A Monte Carlo Study

J. Chow, A. Owrangi, G. Grigorov

Research output: Contribution to journalArticle

Abstract

Purpose: This study evaluated the dosimetric impact of surface dose reduction due to the loss of backscatter from the bone interface in superficial x‐ray radiation therapy. Monte Carlo simulation was carried out using the EGSnrc code. Methods: An inhomogeneous phantom containing a thin layer of tissue (1,3 and 5 mm) on top of a bone (thickness = 1 cm) was irradiated by a clinical 105 kVp photon beam produced by a Gulmay D3225 kV x‐ray machine. The field size and SSD was equal to 5 cm diameter and 20 cm, respectively. Surface doses for different phantom configurations were calculated using the DOSXYZnrc code. Photon energy spectra at the phantom and bone surface were determined according to phase‐space files at the particle scoring planes. For comparison, all Monte Carlo simulations were repeated in a phantom with the bone replaced by soft tissue. Results: Surface dose reduction was found when a bone was underneath the tissue layer. When the tissue thickness = 1 mm, a surface dose reduction of 3.5% was found. The dose reduction decreased to 2.1% and 1.8% when the tissue thickness increased to 3 and 5 mm, respectively. This shows that the impact of the surface dose uncertainty decreased while the tissue thickness on top of the bone increased. This result was supported by the decrease of intensity in the photon energy spectrum, when the tissue layer was with and over the bone, compared to without the bone. Conclusions: Surface dose reduction of 3.5%–1.8% was found when the tissue layer increased from 1 to 5 mm. This decrease of surface dose results in an overestimation of prescribed dose at the patient's surface, and should be a concern when using superficial x‐ray to treat skin tumours in sites such as forehead, chest wall and kneecap.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume38
Issue number6
DOIs
StatePublished - Jan 1 2011

Fingerprint

X-Ray Therapy
Radiotherapy
Bone and Bones
Photons
X-Rays
Silver Sulfadiazine
Forehead
Patella
Thoracic Wall
Uncertainty
Skin

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐693 : Surface Dose Reduction from Bone Interface in Superficial X‐Ray Radiation Therapy: A Monte Carlo Study. / Chow, J.; Owrangi, A.; Grigorov, G.

In: Medical Physics, Vol. 38, No. 6, 01.01.2011.

Research output: Contribution to journalArticle

@article{5d51b8c224394539af5a036b0a05e304,
title = "SU‐E‐T‐693: Surface Dose Reduction from Bone Interface in Superficial X‐Ray Radiation Therapy: A Monte Carlo Study",
abstract = "Purpose: This study evaluated the dosimetric impact of surface dose reduction due to the loss of backscatter from the bone interface in superficial x‐ray radiation therapy. Monte Carlo simulation was carried out using the EGSnrc code. Methods: An inhomogeneous phantom containing a thin layer of tissue (1,3 and 5 mm) on top of a bone (thickness = 1 cm) was irradiated by a clinical 105 kVp photon beam produced by a Gulmay D3225 kV x‐ray machine. The field size and SSD was equal to 5 cm diameter and 20 cm, respectively. Surface doses for different phantom configurations were calculated using the DOSXYZnrc code. Photon energy spectra at the phantom and bone surface were determined according to phase‐space files at the particle scoring planes. For comparison, all Monte Carlo simulations were repeated in a phantom with the bone replaced by soft tissue. Results: Surface dose reduction was found when a bone was underneath the tissue layer. When the tissue thickness = 1 mm, a surface dose reduction of 3.5{\%} was found. The dose reduction decreased to 2.1{\%} and 1.8{\%} when the tissue thickness increased to 3 and 5 mm, respectively. This shows that the impact of the surface dose uncertainty decreased while the tissue thickness on top of the bone increased. This result was supported by the decrease of intensity in the photon energy spectrum, when the tissue layer was with and over the bone, compared to without the bone. Conclusions: Surface dose reduction of 3.5{\%}–1.8{\%} was found when the tissue layer increased from 1 to 5 mm. This decrease of surface dose results in an overestimation of prescribed dose at the patient's surface, and should be a concern when using superficial x‐ray to treat skin tumours in sites such as forehead, chest wall and kneecap.",
author = "J. Chow and A. Owrangi and G. Grigorov",
year = "2011",
month = "1",
day = "1",
doi = "10.1118/1.3612655",
language = "English (US)",
volume = "38",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐693

T2 - Surface Dose Reduction from Bone Interface in Superficial X‐Ray Radiation Therapy: A Monte Carlo Study

AU - Chow, J.

AU - Owrangi, A.

AU - Grigorov, G.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Purpose: This study evaluated the dosimetric impact of surface dose reduction due to the loss of backscatter from the bone interface in superficial x‐ray radiation therapy. Monte Carlo simulation was carried out using the EGSnrc code. Methods: An inhomogeneous phantom containing a thin layer of tissue (1,3 and 5 mm) on top of a bone (thickness = 1 cm) was irradiated by a clinical 105 kVp photon beam produced by a Gulmay D3225 kV x‐ray machine. The field size and SSD was equal to 5 cm diameter and 20 cm, respectively. Surface doses for different phantom configurations were calculated using the DOSXYZnrc code. Photon energy spectra at the phantom and bone surface were determined according to phase‐space files at the particle scoring planes. For comparison, all Monte Carlo simulations were repeated in a phantom with the bone replaced by soft tissue. Results: Surface dose reduction was found when a bone was underneath the tissue layer. When the tissue thickness = 1 mm, a surface dose reduction of 3.5% was found. The dose reduction decreased to 2.1% and 1.8% when the tissue thickness increased to 3 and 5 mm, respectively. This shows that the impact of the surface dose uncertainty decreased while the tissue thickness on top of the bone increased. This result was supported by the decrease of intensity in the photon energy spectrum, when the tissue layer was with and over the bone, compared to without the bone. Conclusions: Surface dose reduction of 3.5%–1.8% was found when the tissue layer increased from 1 to 5 mm. This decrease of surface dose results in an overestimation of prescribed dose at the patient's surface, and should be a concern when using superficial x‐ray to treat skin tumours in sites such as forehead, chest wall and kneecap.

AB - Purpose: This study evaluated the dosimetric impact of surface dose reduction due to the loss of backscatter from the bone interface in superficial x‐ray radiation therapy. Monte Carlo simulation was carried out using the EGSnrc code. Methods: An inhomogeneous phantom containing a thin layer of tissue (1,3 and 5 mm) on top of a bone (thickness = 1 cm) was irradiated by a clinical 105 kVp photon beam produced by a Gulmay D3225 kV x‐ray machine. The field size and SSD was equal to 5 cm diameter and 20 cm, respectively. Surface doses for different phantom configurations were calculated using the DOSXYZnrc code. Photon energy spectra at the phantom and bone surface were determined according to phase‐space files at the particle scoring planes. For comparison, all Monte Carlo simulations were repeated in a phantom with the bone replaced by soft tissue. Results: Surface dose reduction was found when a bone was underneath the tissue layer. When the tissue thickness = 1 mm, a surface dose reduction of 3.5% was found. The dose reduction decreased to 2.1% and 1.8% when the tissue thickness increased to 3 and 5 mm, respectively. This shows that the impact of the surface dose uncertainty decreased while the tissue thickness on top of the bone increased. This result was supported by the decrease of intensity in the photon energy spectrum, when the tissue layer was with and over the bone, compared to without the bone. Conclusions: Surface dose reduction of 3.5%–1.8% was found when the tissue layer increased from 1 to 5 mm. This decrease of surface dose results in an overestimation of prescribed dose at the patient's surface, and should be a concern when using superficial x‐ray to treat skin tumours in sites such as forehead, chest wall and kneecap.

UR - http://www.scopus.com/inward/record.url?scp=85024821931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024821931&partnerID=8YFLogxK

U2 - 10.1118/1.3612655

DO - 10.1118/1.3612655

M3 - Article

AN - SCOPUS:85024821931

VL - 38

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -